技术情报 |
|
|
|
|
基因编辑技术发展态势分析与建议* |
许丽,王玥,姚驰远,徐萍() |
中国科学院上海生命科学研究院 上海 200031 |
|
Trends and Development Bottleneck Analysis of Gene Editing Technology |
XU Li,WANG Yue,YAO Chi-yuan,XU Ping() |
Shanghai Information Center of Life Sciences,Shanghai Information Center for Life Sciences,CAS,Shanghai 200031,China |
引用本文:
许丽, 王玥, 姚驰远, 徐萍. 基因编辑技术发展态势分析与建议*[J]. 中国生物工程杂志, 2018, 38(12): 113-122.
XU Li, WANG Yue, YAO Chi-yuan, XU Ping. Trends and Development Bottleneck Analysis of Gene Editing Technology. China Biotechnology, 2018, 38(12): 113-122.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20181214
或
https://manu60.magtech.com.cn/biotech/CN/Y2018/V38/I12/113
|
[1] |
Jinek M,Chylinski K,Fonfara I,et al.A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.Science,2012,337:816-821.
|
[2] |
Cong L,Ran F A,Cox D,et al.Multiplex genome engineering using CRISPR/Cas systems.Science,2013,339(6121):819-823.
doi: 10.1126/science.1229223
|
[3] |
Komor A C,Kim Y B,Packer M S,et al.Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.Nature,2016,7630(533):420-424.
|
[4] |
Gaudelli N M,Alexis C.Komor,Holly A.Rees,et al.Programmable base editing of A·T to G·C in genomic DNA without DNA cleavage.Nature,2017,551:464-471.
|
[5] |
Cox D B T,Gootenberg J S, Abudayyeh O O, et al.RNA editing with CRISPR-Cas13.Science,2017, 358(6366) :1019-1027.
doi: 10.1126/science.aaq0180
pmid: 29070703
|
[6] |
Li X S, Wang Y, Liu Y J, et al.Base editing with a Cpf1-cytidine deaminase fusion.Nature Biotechnology,2018,36:324-327.
|
[7] |
Wang X,Li J N,Wang Y,et al.Efficient base editing in methylated regions with a human APOBEC3A-Cas9 fusion.Nature Biotechnology,2018.08.20 (Online).
doi: 10.1038/nbt.4198
|
[8] |
Charlesworth C T,Deshpande P S,Dever D P,et al.Identification of pre-existing adaptive immunity to Cas9 proteins in humans.BioRxiv, 2018,36:946-949
|
[9] |
Haapaniemi E,Botla S,Persson J,et al.CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response.Nature Medicine,2018,24:927-930.
doi: 10.1038/s41591-018-0049-z
pmid: 29892067
|
[10] |
Ihry R J,Worringer K A,Salick M R,et al.p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells.Nature Medicine,2018,24:939-946.
doi: 10.1038/s41591-018-0050-6
pmid: 29892062
|
[11] |
Adikusuma F,Piltz S,Corbett M A,et al.Large deletions induced by Cas9 cleavage.Nature,2018,560:E8-E9.
doi: 10.1038/s41586-018-0380-z
|
[12] |
Slaymaker I M,Gao L Y,Zetsche B,et al.Rationally engineered Cas9 nucleases with improved specificity.Science,2015,351(6268):84-88.
doi: 10.1126/science.aad5227
pmid: 4714946
|
[13] |
Kleinstiver B P,Pattanayak V,Prew M S,et al.High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.Nature,2016,529:490-495.
|
[14] |
Ran F A,Cong L,Yan W X,et al.In vivo genome editing using Staphylococcus aureus Cas9.Nature,2015,520:186-191.
|
[15] |
Liao H K,Hatanaka F,Toshikazu Araoka,et al.In vivo target gene activation via CRISPR/Cas9-mediated trans-epigenetic modulation.Cell,2017,171(7):1497-1507.
doi: 10.1016/j.cell.2017.10.025
pmid: 29224783
|
[16] |
Liu Y C,Zhan Y H,Chen Z C,et al.Directing cellular information flow via CRISPR signal conductors. Nature Methods, 2016,13:938-944.
doi: 10.1038/nmeth.3994
pmid: 27595406
|
[17] |
Zuo E W,Huo X N,Yao X,et al.CRISPR/Cas9-mediated targeted chromosome elimination. Genome Biology, 2017,18:224.
doi: 10.1186/s13059-017-1354-4
pmid: 29178945
|
[18] |
Zetsche B,Gootenberg J S,Abudayyeh O O,et al.Cpf1 is a single RNA-Guided endonuclease of a class 2 CRISPR-Cas system.Cell,2015,163(3):759-771.
doi: 10.1016/j.cell.2015.09.038
pmid: 26422227
|
[19] |
Burstein D,Harrington L B,Strutt S C,et al.New CRISPR-Cas systems from uncultivated microbes.Nature,2017,542:237-241.
doi: 10.1038/nature21059
pmid: 28005056
|
[20] |
Abudayyeh O O,Gootenberg J S,Konermann S,et al.C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector.Science,2016,353(6299):aaf5573.
doi: 10.1126/science.aaf5573
pmid: 27256883
|
[21] |
Smargon A A,Cox D B T,Pyzocha N K,et al.Cas13b is a type VI-B CRISPR-associated RNA-guided Rnase differentially regulated by accessory proteins Csx27 and Csx28.Molecular Cell,2017,65(4):618-630.
doi: 10.1016/j.molcel.2016.12.023
pmid: 5432119
|
[22] |
Hu J H,Miller S M,Geurts M H,et al.Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.Nature,2018,556:57-63.
doi: 10.1038/nature26155
pmid: 29512652
|
[23] |
Konermann S,Lotfy P,Brideau N J,et al.Transcriptome engineering with RNA-Targeting type VI-D CRISPR effectors.Cell,2018,173(3):665-676.
doi: 10.1016/j.cell.2018.02.033
pmid: 29551272
|
[24] |
Zetsche B,Heidenreich M,Mohanraju P,et al.Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array.Nature Biotechnology,2017,35(1):31-34.
doi: 10.1038/nbt.3737
pmid: 27918548
|
[25] |
Liu L,Li X Y,Wang J Y,et al.Two distant catalytic sites are responsible for C2c2 RNase activities.Cell,2017,168:1-2.
|
[26] |
Liu L,Li X Y,Ma J,et al.The molecular architecture for RNA-guided RNA cleavage by Cas13a.Cell,2017,170(4):714-726.
doi: 10.1016/j.cell.2017.06.050
pmid: 28757251
|
[27] |
Levasseur A,Bekliz M,Chabrière E,et al.MIMIVIRE is a defence system in mimivirus that confers resistance to virophage.Nature,2016,531:249-252.
doi: 10.1038/nature17146
pmid: 26934229
|
[28] |
Nishida K,Arazoe T,Yachie N,et al.Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems.Science,2016,353(6305):aaf8729.
|
[29] |
Xu S,Cao S S,Zou B J,et al.An alternative novel tool for DNA editing without target sequence limitation: the structure-guided nuclease.Genome Biology,2016,17:186.
doi: 10.1186/s13059-016-1038-5
pmid: 27634179
|
[30] |
Xu W,Liu Y C,Liu Y L,et al.Artificial small RNA for sequence specific cleavage of target RNA through RNase III endonuclease Dicer.Oncotarget,2016,7(34):54549-54554.
doi: 10.18632/oncotarget.9582
pmid: 27231846
|
[31] |
Shan Q W,Wang Y P,Li J,et al.Targeted genome modification of crop plants using a CRISPR-Cas system.Nature Biotechnology,2013,31:686-688.
doi: 10.1038/nbt.2650
pmid: 23929338
|
[32] |
Bassuk A G,Zheng Z,Li Y,et al.Precision medicine: genetic repair of retinitis pigmentosa in patient-derived stem cells.Scientific Reports,2016,6:19969.
doi: 10.1038/srep19969
pmid: 4728485
|
[33] |
Nelson C E,Hakim C H,Ousterout D G,et al.In vivo genome editing improves muscle function in a mouse model of duchenne muscular dystrophy.Science,2016,351(6271):403-407.
|
[34] |
Chen Z H,Yu Y P,Zuo Z H,et al.Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene.Nature Biotechnology,2017,35:543-550.
doi: 10.1038/nbt.3843
pmid: 28459452
|
[35] |
Kaminski R,Chen Y L,Fischer T,et al.Elimination of HIV-1 genomes from human t-lymphoid cells by CRISPR/Cas9 gene editing.Scientific Reports,2016,6,Article number: 22555.
|
[36] |
Yang L H,Zhou X Y,Gang Wang,et al.Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9.Science,2017,357(6357):1303-1307.
doi: 10.1126/science.aan4187
pmid: 28798043
|
[37] |
Liang P P,Xu Y W,Zhang X Y,et al.CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes.Protein & Cell,2015,6(5):363-372.
doi: 10.1007/s13238-015-0153-5
pmid: 25894090
|
[38] |
Ma H,Marti-Gutierrez N,Sang-Wook P,et al.Correction of a pathogenic gene mutation in human embryos.Nature,2017,548:413-419.
doi: 10.1038/nature23305
pmid: 28783728
|
[39] |
Niu Y Y,Shen B,Cui Y Q,et al.Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos.Cell,2014,156(4):836-843.
doi: 10.1016/j.cell.2014.01.027
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|